Your browser doesn't support javascript.
loading
The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience.
Gier, Chad; Gilchrist, Ian; Fordham, Matthew; Riordan, Luke; Milchan, Ella; Patel, Nidhi; Mohedi, Azad; Choudhury, Sahana; Kits, Tara; Cohen, Regina; Doughtery, Joseph; Reilly, John P; Kalogeropoulos, Andreas; Rahman, Tahmid; Chen, On.
Afiliação
  • Gier C; Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States.
  • Gilchrist I; Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States.
  • Fordham M; Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States.
  • Riordan L; Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States.
  • Milchan E; Stony Brook Renaissance School of Medicine, Stony Brook, NY, United States.
  • Patel N; Stony Brook Renaissance School of Medicine, Stony Brook, NY, United States.
  • Mohedi A; Stony Brook Renaissance School of Medicine, Stony Brook, NY, United States.
  • Choudhury S; Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States.
  • Kits T; Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States.
  • Cohen R; Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States.
  • Doughtery J; Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States.
  • Reilly JP; Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States.
  • Kalogeropoulos A; Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States.
  • Rahman T; Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States.
  • Chen O; Stony Brook Heart Institute, Stony Brook University Hospital, Stony Brook, NY, United States.
Front Cardiovasc Med ; 11: 1284562, 2024.
Article em En | MEDLINE | ID: mdl-38333418
ABSTRACT
Dyslipidemia is a leading contributor to atherosclerotic cardiovascular disease (ASCVD). There has been a significant improvement in the treatment of dyslipidemia in the past 10 years with the development of new pharmacotherapies. The intent of this review is help enhance clinicians understanding of non-statin lipid lowering therapies in accordance with the 2022 American College of Cardiology Expert Consensus Clinical Decision Pathway on the Role of Non-statin Therapies for LDL-Cholesterol Lowering. We also present a single-center experience implementing a systematic inpatient protocol for lipid lowering therapy for secondary prevention of ASCVD.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article